Inhibition of osteoclastogenesis by the RNA-binding protein QKI5: a novel approach to protect from bone resorption.
Increased osteoclastogenesis is a common feature of bone erosion, notably in osteoporosis but also in inflammatory diseases such as rheumatoid arthritis (RA) and osteoarticular infections. Human Cytomegalovirus (HCMV) infection has been previously described to impair monocytes differentiation into macrophages and dendritic cells. However, its effect on monocyte-derived osteoclast is yet to be determined. We demonstrated here that in vitro HCMV infection is associated with an inhibition of osteoclastogenesis through a decreased expression of CSF-1R and RANK in monocytes which was mediated by an upregulation of QKI5, a cellular RNA-interacting protein. We evidenced that deliberate QKI5 overexpression in the absence of HCMV infection context is able to decrease CSF-1R and RANK expression, leading to osteoclastogenesis inhibition. Finally, by using lentiviral vectors in a calvarial bone erosion mouse model, we showed that QKI5 inhibits bone degradation. This manuscript identifies QKI5 as a strong inhibitor of bone resorption. Future research will point out whether QKI5 could be a target for bone pathologies. This article is protected by copyright. All rights reserved.